Nachrichten zur STAAR Surgical Company Aktie

STAAR Surgical (STAA) im Pivotal-Point-Check: China-Rebound bei implantierbaren Kontaktlinsen pulverisiert die Erwartungen mit 90 Mio. USD Quartalsumsatz!

Umsatzsprung: Vorläufige Zahlen für das 1. Quartal 2026 liegen mit über 90 Mio. USD massiv über den Erwartungen von…

STAAR Surgical surges as Canaccord Genuity raises to Buy on Q1 sales

…

Surging Earnings Estimates Signal Upside for Staar Surgical (STAA) Stock

Staar Surgical (STAA) shares have started gaining and might continue moving higher in the near term, as indicated by solid…

Staar Surgical (STAA) Lags Q4 Earnings and Revenue Estimates

Staar Surgical (STAA) delivered earnings and revenue surprises of -75.51% and -23.60%, respectively, for the quarter ended December 2025. Do…

STAA Gains FDA Nod to Expand EVO ICL Age Indication to 60 Years

STAAR Surgical jumps 8% after the FDA expands the EVO ICL age range to 21-60, backed by strong safety data…

Alcon wird US-Unternehmen Staar Surgical nicht übernehmen

VERNIER (dpa-AFX) - Der Augenheilkunde-Konzern Alcon wird das US-Unternehmen Staar Surgical nicht übernehmen. Die Gegenwehr aus Aktionärskreisen von…

Broadwood sees $50/share path for STAAR Surgical as merger battle nears voting day By Investing.com

Broadwood sees $50/share path for STAAR Surgical as merger battle nears voting day…

Battle for STAAR Surgical intensifies as Glass Lewis reiterates recommendation By Investing.com

Battle for STAAR Surgical intensifies as Glass Lewis reiterates recommendation…

STAAR Surgical accuses activist Broadwood of ’misinformation campaign’ By Investing.com

STAAR Surgical accuses activist Broadwood of ’misinformation campaign’…

Healthcare Investor Exits $13 Million Stake STAAR Surgical Stake as Alcon Deal Drama Looms

One specialist investor just walked away from STAAR Surgical entirely—right as uncertainty over a delayed Alcon deal looms.…

STAAR Surgical opens go-shop window amid shareholder revolt over Alcon deal By Investing.com

STAAR Surgical opens go-shop window amid shareholder revolt over Alcon deal…

Alcon, Broadwood trade blows in fight for STAAR Surgical’s future By Investing.com

Alcon, Broadwood trade blows in fight for STAAR Surgical’s future…

Alcon rejects request for higher offer in STAAR Surgical deal By Investing.com

Alcon rejects request for higher offer in STAAR Surgical deal…

Key deals this week: STAAR Surgical, Pfizer, DB Insurance, Strive, Rocket Lab and more

…

Staar Surgical (STAA) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Staar Surgical (STAA) give a sense of how its business performed in the quarter…

Stocks making the biggest moves midday: Pfizer, Palantir, Coinbase, Staar Surgical and more

These are some of the stocks posting the largest midday moves.…

STAAR Surgical stock soars after Alcon announces $1.5B acquisition By Investing.com

STAAR Surgical stock soars after Alcon announces $1.5B acquisition…

Staar Surgical (STAA) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Although the revenue and EPS for Staar Surgical (STAA) give a sense of how its business performed in the quarter…

STAAR Surgical stock plummets as Q4 results miss estimates, outlook disappoints By Investing.com

STAAR Surgical stock plummets as Q4 results miss estimates, outlook disappoints…

STAAR Surgical: Growth Story Remains Intact Despite Some Challenges

…

STAAR Surgical Company (STAA): Kursschwäche bietet Kaufgelegenheit - Aufstockung durch Großinvestoren!

STAAR Surgical Company (STAA) ist ein führender Hersteller von implantierbaren Linsen für die Augenchirurgie. Das Hauptprodukt des Unternehmens sind die…

STAAR Surgical: Turning A Blind Eye

…

STAAR Surgical: Expecting A Re-Acceleration In Growth As Investments Materialize

…

Implied Volatility Surging for STAAR Surgical (STAA) Stock Options

Investors need to pay close attention to STAAR Surgical (STAA) stock based on the movements in the options market lately.…

Earnings call: STAAR Surgical posts record Q2 sales, raises 2024 outlook By Investing.com

Earnings call: STAAR Surgical posts record Q2 sales, raises 2024 outlook…

UBS belässt Carl Zeiss Meditec auf Neutral - Ziel 71 Euro

ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Carl Zeiss Meditec auf "Neutral" mit einem Kursziel…

Staar Surgical (STAA) Soars 7.5%: Is Further Upside Left in the Stock?

Staar Surgical (STAA) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings…

STAAR Surgical: Keeping An Eye On The Shares

…

STAAR Surgical Stock: I Dont See A Great Path Forward, Despite The Recent Surge

…

Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength?

Staar Surgical (STAA) saw its shares surge in the last session with trading volume being higher than average. The latest…

Staar Surgical director Aimee Weisner buys $66.7k in shares By Investing.com

Staar Surgical director Aimee Weisner buys $66.7k in shares…

dpa-AFX ProFeed